Pfizer Lifts Revenue Outlook, McDonald’s Sees U.S. Sales Growth in Q3

Pfizer Q3 earnings beat expectations, driven by Paxlovid sales. Cost-saving goals aim for $4B by 2027 as Covid demand slows. Investor concerns rise….
Read More